Inhibition of SHP2 ameliorates the pathogenesis of systemic lupus erythematosus.

Inhibition of SHP2 ameliorates the pathogenesis of systemic lupus erythematosus.

Item
http://www.wikidata.org/entity/Q36951816
Protein tyrosine phosphatase Shp2 deficiency in podocytes attenuates lipopolysaccharide-induced proteinuriaTransancestral mapping and genetic load in systemic lupus erythematosus.The phenolic fraction of extra virgin olive oil modulates the activation and the inflammatory response of T cells from patients with systemic lupus erythematosus and healthy donors.Development and Characterization of an Endotoxemia Model in Zebra Fish.Insights Gained From the Study of Pediatric Systemic Lupus Erythematosus.MicroRNA-326 Upregulates B Cell Activity and Autoantibody Production in Lupus Disease of MRL/lpr Mice.Hyperglycaemia-induced methylglyoxal accumulation potentiates VEGF resistance of diabetic monocytes through the aberrant activation of tyrosine phosphatase SHP-2/SRC kinase signalling axisThe tyrosine phosphatase SHP2 controls TGFβ-induced STAT3 signaling to regulate fibroblast activation and fibrosis
P2860

Inhibition of SHP2 ameliorates the pathogenesis of systemic lupus erythematosus.

Item
http://www.wikidata.org/entity/Q36951816
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Inhibition of SHP2 ameliorates the pathogenesis of systemic lupus erythematosus.
@en
type
label
Inhibition of SHP2 ameliorates the pathogenesis of systemic lupus erythematosus.
@en
prefLabel
Inhibition of SHP2 ameliorates the pathogenesis of systemic lupus erythematosus.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Inhibition of SHP2 ameliorates the pathogenesis of systemic lupus erythematosus
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932